Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Experiences and Memories of French and Algerian Veterans. Remembering the 'petite guerre' in the Aurès-Nememcha (PETITE GUERRE)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: United Kingdom
Call: Marie Skłodowska-Curie Individual Fellowships (IF-EF) (H2020-MSCA-IF-2014, 2014)
Start date: 2015-09-01
End date: 2017-08-31
Duration (months): 24.0
Total project cost (EUR): 183454.8
EU funding (EUR): 183454.8
Participants: 1
Project status: CLOSED

The present study aims to investigate the Algerian War of Independence (1954–62) from a new perspective. It proposes to frame a transnational history of the war, going beyond both the (opposing) French and Algerian (national) narratives, to resituate the war in its Mediterranean, European, and eventually its global contexts. This general research objective, however, will be achieved by using a microhistorical approach: instead of looking at the conflict as a generic “whole” and examining its reverberations in an elusive “collective memory”, the project focuses on a specific region, the Aurès-Nememcha in the Algerian south-east. At the core of this project are the specific experiences and memories of French and Algerian veterans who fought each other for eight years, in this mountainous, Berberophone area. Who were they? What kind of war were they fighting, and why? And fifty years after the ceasefire, how do the citizens of each country cope with their combat memories? The project will mobilise a wide range of sources, mostly but not exclusively French and Algerian. Aiming to analyse both past events and their present memories, this study will rely on both qualitative and quantitative analytical methods, in a truly interdisciplinary framework. Indeed, this “global microhistory” approach—beyond being an original contribution to historical research—aims to offer new knowledge of and insights into the Franco-Algerian War, in order to help the two countries to go beyond the narrow national narratives that continue to fuel an unexhausted “memory war” that is ongoing both between and within Algeria and France. If the efforts of the EU and the Union for the Mediterranean (2008) may help to set a new tone in the near future, today it is less at the state level that it is possible to act than at the level of the people, by focusing on their particular and familial stories.

Keywords: algeria,france,history 20 21th century,algeria war for independence,decolonization,mediterranean,conflicts studies,memory studies,veterans
Ecophysiological and biophysical constraints on domestication in crop plants (CONSTRAINTS)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: Biotechnology and Biosystems Engineering
Panel description: Biotechnology using all organisms, biotechnology for environment and food applications, applied plant and animal sciences, bioengineering and synthetic biology, biomass and biofuels, biohazards
Countries involved: France
Call: ERC Starting Grant (ERC-2014-STG, 2014)
Start date: 2015-06-01
End date: 2021-05-31
Duration (months): 72.0
Total project cost (EUR): 1499979.0
EU funding (EUR): 1499979.0
Participants: 1
Project status: CLOSED

A fundamental question in biology is how constraints drive phenotypic changes and the diversification of life. We know little about the role of these constraints on crop domestication, nor how artificial selection can escape them. CONSTRAINTS questions whether crop domestication has shifted ecophysiological and biophysical traits related to resource acquisition, use and partitioning, and how trade-offs between them have constrained domestication and can limit future improvements in both optimal and sub-optimal conditions. The project is based on three objectives: 1. revealing the existence (or lack) of generic resource-use domestication syndrome in crop science; 2. elucidating ecophysiological and biophysical trade-offs within crop science and delineating the envelope of constraints for artificial selection; 3. examining the shape of ecophysiological and biophysical trade-offs in crop species when grown in sub-optimal environmental conditions. This project will be investigated within and across crop species thanks to a core panel of 12 studied species (maize, sunflower, Japanese rice, sorghum, durum wheat, bread wheat, alfalfa, orchardgrass, silvergrass, pea, colza, vine) for which data and collections (ca. 1,300 genotypes total) are already available to the PI, and additional high throughput phenotyping using automatons. Additional species will be used for specific tasks: (i) a panel of 30 species for a comparative analysis of crop species and their wild progenitors; (ii) 400 worldwide accessions of Arabidopsis thaliana for a genome-wide association study of resource-use traits. Collectively, we will use a multiple-tool approach by using: field measurement, high-throughput phenotyping, common-garden experiment, comparative analysis using databases, modelling, genomics. The ground-breaking nature of the project holds in the nature of the questions asked and in the unique opportunity to transfer knowledge from ecology and evolutionary biology to crop species.

Keywords: domestication,trade off,comparative approach,yield,resource use efficiency,plant ecological strategies,plant traits,phenotypic space,phenotypic integration,plant allometry,resource economics
Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe (EUthyroid)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Preventing disease
Action type: Research and Innovation actions
Countries involved: Iceland,Austria,Italy,Israel,Estonia,Spain,Austria,Germany,Switzerland,Belgium,Bulgaria,Greece,Hungary,Poland,Slovenia,Sweden,Slovakia,Sweden,North Macedonia,Norway,Finland,Croatia,Latvia,France,Czechia,Netherlands,Canada,Denmark,United Kingdom,United Kingdom,Denmark,Portugal
Call: Evaluating existing screening and prevention programmes (H2020-PHC-2014-two-stage, 2014)
Start date: 2015-06-01
End date: 2018-05-31
Duration (months): 36.0
Total project cost (EUR): 3375330.25
EU funding (EUR): 2999949.0
Participants: 35
Project status: CLOSED

Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single most important, preventable cause of brain damage. European ID is due to significant heterogeneity in prevention and monitoring programs, leading to inappropriate interventions, increased disease burden, health inequities and increased health care costs. Up to 360 Million European citizens are exposed to ID disorders. An effective European monitoring program is a crucial step towards eradication of ID disorders with significant benefits for European citizens and the sustainability of health care systems. The effects of ID in total cause tremendous, preventable costs in health care systems of affected regions. The overall aim of EUthyroid is to evaluate ID prevention and monitoring programs in 24 European countries, to initiate capacity building for harmonized European ID prevention and monitoring programs, and to disseminate project outcomes for supporting measures on national and EU level in order to eradicate ID disorders in Europe. The project will position itself as international hub of current national initiatives in the attempt to coordinate and support existing national activities. EUthyroid will generate the first harmonized data set of ID resulting in the first valid map of iodine status in Europe. With a dedicated dissemination program about the unfavorable health outcomes of ID, EUthyroid will pave the way for a harmonized EU-wide regulation of iodination, a common approach to iodine and outcome monitoring and establish recommendations for scientists on how to monitor IDD prevention programs. The project aims to make Europe a benchmark for ID disorder prevention worldwide.

Keywords: iodine deficiency,thyroid disorders,cognitive function,monitoring,outcome research,registries,health economics
ORganisational BEhaviour with new TEChnologies: a human resources management model for industry 4.0 (ORBETEC)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Society and Enterprise panel
Action type: Marie Skłodowska-Curie actions
Panel: Economic Sciences
Countries involved: Italy
Call: Individual Fellowships (H2020-MSCA-IF-2017, 2017)
Start date: 2018-09-17
End date: 2020-09-16
Duration (months): 24.0
Total project cost (EUR): 168277.2
EU funding (EUR): 168277.2
Participants: 1
Project status: CLOSED

Research related to the fourth Industrial Revolution is growing up and are a major asset for prosperity and European economic growth. However, the effect of human resources management in relation to industry 4.0 remains few investigated in the field of Work and Organizational Psychology. In view of the constantly evolving dynamics favouring the implementation of new technologies in organizations (autonomous robots, virtual reality, big data, and so on), it is now essential to define a model adapted to industry 4.0. The objective of ORBETEC project is to generate a model of human resources management, targeting four essential areas (organizational development, professional development, competence development, and compensation/reward), applied to the reality of industry 4.0. The research will take place in Foligno (IT) in a highly technological organization, the Umbra Cuscinetti S.p.A (Umbra Group headquarters), world leader in the production of recirculating ball screws in the aeronautic sector. Beatrice Baldaccini (Supervisor) and Carlo Odoardi (Professor Key person) will provide researchers’ supervision and training. The use of a qualitative and quantitative methodology via multilevel and longitudinal statistics will allow the study of the organizational behaviours generated inside evolving and highly innovative organizations. Two secondments will be determined in order to strengthen the international and interdisciplinary aspect of the ORBETEC project. ORBETEC will be one of the few researches to explore Industry 4.0 in the field of organizational behaviour and will contribute to the definition of an international human resource management model. The results will be disseminated in peer-reviewed international journals and interdisciplinary training will propel the researcher at European expert level. Finally, ORBETEC will improve the performance, productivity and work-life quality of a company with an economic impact at regional, national and European level.

Keywords: industrial innovaton,human factor,performance,industrie 4 0,organisational behaviour,new technologies,robotics
CATALYTIC ENANTIOSELECTIVE DESYMMETRIZATION OF PHOSPHORUS (V) CENTERS (DESYPHOR)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: United Kingdom
Call: Individual Fellowships (H2020-MSCA-IF-2020, 2020)
Start date: 2021-08-15
End date: 2023-08-14
Duration (months): 24.0
Total project cost (EUR): 212933.76
EU funding (EUR): 212933.76
Participants: 1
Project status: SIGNED

Compounds containing one or more phosphorous atoms in the P(V) oxidation state are important to chemistry, biology and medicine. These include marketed antiviral drugs such as Remdesivir, and Sofosbuvir; the former garnering interest as a potential treatment for COVID-19, and the latter being on the WHO list of essential medicines for the treatment of Hepatitis C. Accordingly, new and improved methods for the efficient synthesis of P(V) containing compounds, especially in an enantioselective fashion are essential. Although promising protocols are beginning to arise for the synthesis of racemic P(V) compounds, new strategic approaches for the stereoselective synthesis of P-stereogenic centres are limited and catalytic enantioselective approaches remain unknown. Herein we propose to exploit our modular and tunable superbase catalyst platform, to design, discover and develop new iminophosphorane catalyst systems that will allow the direct and enantioselective synthesis of chiral phosphates, phosphonates and their analogues, in a single enantioselective step. We wish to capitalise on the abundance of commercial phosphorous (V) starting materials to allow the ready and scalable preparation of suitable symmetric prochiral precursors and through a suitable catalyst-enabled desymmetrization generate, in high enantiomeric excess, synthetically relevant chiral phosphorous intermediates. The fellow has already acquired a notable, high-level skill set and has demonstrated his excellence throughout his career, however this challenging project will extend his capabilities and improve his skill base and further enhance his scientific potential. DESYPHOR will therefore bring vital new knowledge to the field of catalytic enantioselective desymmetrization, deliver important methodological tools to researchers across the globe and accordingly will advance the excellent standing of the candidate, the host laboratory in Oxford, and of European science in general.

Keywords: catalytic,enantioselective,superbase
Value-based Healthcare Platform Secured with Blockchain Technology (DigiPharm)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Switzerland
Call: SME instrument (H2020-SMEInst-2018-2020-1, 2019)
Start date: 2019-12-01
End date: 2020-04-30
Duration (months): 5.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

The healthcare is under pressure to spend the resources efficiently and to shift to payments by using a 'value-based' approach, where the price is determined by treatment performance and patient outcomes. However, the transition is hindered by the inadequate infrastructure, the pricing confidentiality issues, and the resistance of some stakeholders against the change. DigiPharm aims to accelerate the value-based healthcare transition with a blockchain-based smart-contracting solution and a highly disruptive business model. The solution, the award-winning DigiPharm platform drastically eases the administrative burden, eliminates errors, and potential frauds in admin operation. As a new element in healthcare, DigiPharm has introduced a cryptocurrency (DPH), as a part of an incentive system. Within the total healthcare market, DigiPharm competes in the healthcare contract management software market that will reach $755M in 2019 with CAGR of 18% in the next years. The solution has raised interest from the UK National Health Service, Roche corporation, the Oman and Dubai Health Authorities, and the Pakistani Government, with whom the company is in negotiation to test the platform. The company would like to launch the full solution in 2022 with a revenue target of €11M by 2026, although they face substantial entry barriers, such as the reluctance to switch from conventional methods and the continued funding need. In order to mitigate the risk of market introduction, Digipharm applies for the SME Tool phase 1 grant to validate DigiPharm’s business viability, asses the further technical development needs, and the update our initial commercialization plan. Currently, ten people are involved in the project development, headed by Ahmed Abdulla, CEO, health economist, an expert at UN/CEFACT, supported by a team of professionals both from the business development area and the value-based healthcare technologies.

Keywords: smart contracting,blockchain technology,cryptocurrency,tokenization,fee for performance
Anti-lock braking system for e-bikes able to avoid the front wheel locking and the rear wheel lifting increasing cyclist safety during braking (BB6S Active)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Italy
Call: SME instrument (H2020-SMEInst-2018-2020-2, 2018)
Start date: 2018-06-01
End date: 2020-05-31
Duration (months): 24.0
Total project cost (EUR): 3263500.0
EU funding (EUR): 2284450.0
Participants: 2
Project status: CLOSED

We are BluBrake and represent a high-tech European SME specialized in active braking control in two wheeled vehicles. We have a clear mission: we aim to increase safety and riding experience for cyclists and become a worldwide reference technology provider of ABS technology in the electric bike industry. Nowadays, ABS technology is widely spread in car and motorbike market: the shift of this technology to electric bike market requires great efforts in terms of portability and integration and foresees more criticalities in terms of system weight and energy consumption compared to the motorbike market. Nevertheless, the ABS has the potential to become a safety standard equipment in premium electric bike market, as confirmed by the ultra-high willingness to spend from target customers. To respond to this market demand, we have developed BB6S Active, the lightest ABS system for electric bikes. The performances of the prototypal system has been verified and tested on several real road surfaces (such as dry and wet asphalt, gravel, off-road, wet conditions) in operational environment (TRL7). We can rely on the support of high-level partnerships with braking system manufacturers that have successfully integrated our ABS system in their products. BB6S Active product specifications are defined to be disruptive against the potential benchmark product: the ABS for e-bikes produced by Robert Bosch GmbH that will enter the market in Q4 2018 BB6S Active is the BluBrake pivotal entrepreneurial initiative, expected to boost magnitude of the SME business. The investment needed to industrialize the BB6S Active system and reach TRL9 is 3,25M€. TAM: e-bike market in EU, US, Canada, Japan and Australia (sales projections = 4,2M of e-bikes in 2022) BB6S Active targets the premium e-bike segment = 40% of the reference market BB6S Active sales forecast: We plan to sell + 250k units in 3,3 years (Q4 2019-2022) by reaching the 8,6% of market penetration and 24M€ of revenues in 2022.

Keywords: anti lock braking system,abs for electric bikes,control algorithms,artificial intelligence,road safety,for cyclists
The Physics of Galaxies 7 Gyr Ago (LEGA-C)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Consolidator grants
Action type: ERC actions
Panel: Universe sciences
Panel description: Astro-physics/-chemistry/-biology; solar system; planetary systems; stellar, galactic and extragalactic astronomy; cosmology; space sciences; astronomical instrumentation and data
Countries involved: Germany,Belgium
Call: ERC Consolidator Grant (ERC-2015-CoG, 2015)
Start date: 2016-04-01
End date: 2022-09-30
Duration (months): 78.0
Total project cost (EUR): 1884875.0
EU funding (EUR): 1036658.61
Participants: 2
Project status: CLOSED

Over the past decade, redshift surveys and multi-wavelength imaging campaigns have drawn up an empirical picture of how many stars had formed in which types of galaxies over the history of the universe. However, we have yet to unravel the individual pathways along which galaxies evolve, and the physical processes that drive them. Continuing with the previous approach -- larger and deeper photometric samples -- is not adequate to achieve this goal. A change of focus is required. In this ERC project I will embark on a new way to address the question of galaxy evolution. I will do so as Principle Investigator of the recently approved LEGA-C observing program that has been allocated 128 nights of observation time over the next 4 years with ESO's flagship facility the Very Large Telescope. This new survey will produce for 2500 distant (at z~1) galaxies with, for the first time, sufficient resolution and S/N to measure ages and chemical compositions of their stellar populations as well as internal velocity dispersions and dynamical masses. This will provide an entirely new physical description of the galaxy population 7 Gyr ago, with which I will finally be able solve long-standing questions in galaxy formation that were out of reach before: what is the star-formation history of individual galaxies, why and how is star-formation ``quenched'' in many galaxies, and to what extent do galaxies grow subsequently through merging afterward? LEGA-C is worldwide the largest spectroscopic survey of distant galaxies to date, and ERC funding will be absolutely critical in harvesting this unparallelled database. I am seeking to extend my research group to realize the scientific potential of this substantial investment (6.5M Eur) of observational resources by the European astronomy community. Timing of the execution of the VLT program is perfectly matched with the timeline of this ERC program.